Blue Horseshoe Stocks: CGC Review & More

Canopy Growth Corp. CGC

One of yesterday morning’s fresh options ideas, the CGC 09/21 $30-40 Calls turned in a very nice intraday performance. Despite the stock posting a red candle on the day, the activity still provided us with some excellent chances to score a quick profit.

It stemmed from beverage giant Constellation Brands increasing its stake in Canopy by a whopping $4B. Here are the gains that were on the table as a result, making this another fantastic call on our part.

$30 Calls – Range: 1.76-3.81 – Max Gain:  62%
$35 Calls – Range: .56-1.50 – Max Gain: 40%
$40 Calls – Range: .16-.56 – Max Gain: 51%


Walmart, Inc. WMT

For today, some of the most promising options plays are likely to be in the WMT chain. The company posted a bigger Q2 sales boost than it has in a full decade. To correlate with the spike in attention and activity we are going to signal a range of calls to monitor into the end of the week.

We’ll be tracking the WMT Weekly $97-101 Calls, which should score some good opportunities on a likely dip-and-rip scenario this morning.


Extended Watchlist:
SYMC, AMW, VNRX, WUBA, OSTK, LAC, LFVN

Blue Horseshoe Stocks: WMT Options & More

Walmart, Inc. WMT – Options Idea

Walmart was already building a nice head of steam on the chart in the weeks leading up to this morning’s earnings release. Things have kicked up a notch this morning as Walmart recorded a resounding across-the-board beat, including an online sales increase of 33%

Given that we are always looking out for opportunities to trade options on the heels of a solid earnings beat, we are going to slate some Walmart calls for observation this morning.

We’ll be tracking the WMT Weekly $86.50-88.50 Calls after what we expect should be a dip-and-rip scenario.


Altimmune, Inc. ALT

We would also like to make mention of ALT this morning, after taking notice of the significant pickup in both price action and volatility yesterday.

That was preceded by a lengthy consolidation period as you can see on the snapshot below, and at the present time, the stock is beginning to come off of being oversold. We’ll watch this one for a potential recovery play in upcoming sessions.


Extended Watchlist:
BDSI, BIOC, BLNK, IMMU, FRED, NOG

Blue Horseshoe Stocks: SGSI Recap & More

McDonalds Corp. MCD

First up today is a quick recap of the performances of the three sets of contracts we tagged for observation in yesterday morning’s premarket report, the MCD Weekly $160-165 Calls.

Regardless of the strike point chosen, there were formidable moves in each of our highlighted ideas.

$380 Calls – Range: 4.25-7.90 – Max Gain: 86%
$382.50 Calls – Range: 2.50-5.60 – Max Gain: 124%
$385 Calls – Range: 1.15-3.40 – Max Gain: 196%

_____

Fresh Options Ideas:
AAPL 06/01 $167.50 & $170 Calls
WMT 06/01 $90-92 Calls


Eleven Biotherapeutics, Inc. EBIO

Our most recent mention of EBIO came just a week ago on April 23rd, and we felt it was time this morning to come back to this play and comment on the excellent performance we’ve seen from it since then.

Our observed low on the stock was 1.83 on the 23rd, and it hasn’t looked back, reaching a high of 2.86, which represents a respectable upswing of 56%


Spectrum Global Solutions, Inc. SGSI

Last but not least, we have SGSI, which we slated for observation on April 25th, and from thoe low we observed that day of .0055, we’ve seen a solid double-bagger from the stock as it has run to a high of .012, for a 118% rise.

SGSI reached that high yesterday on over 10X the average volume, in addition to there being quite a bit of From-4 activity in the company’s disclosure feed. We’ll continue to keep our eye on it.


Extended Watchlist:
HBI, HTBX, MTZ, UAVS, HLIT, GSUM

Blue Horseshoe Stocks: ENPH Review & More

Enphase Energy, Inc. ENPH – Review

We have been exceedingly pleased with the recent performance of ENPH, which, despite recent volatility in the markets at large, has been on an incredible bull run for several weeks. We alerted our readers to ENPH’s momentum on the last day of February, and in the two trading weeks since then, the stock has barely skipped a beat.

From a low of 3.07 on the morning of our initial alert, we’ve seen ENPH steadily rise, leading to a new high of 4.74 on Friday. That works out to a very solid run of 54% In the last week especially , the stock showed little sign of slowing down, so we’ll be interested to see where its fortunes take it this week.


Walmart, Inc. WMT – Options Review

We’ve been tracking a wide range of extended-term WMT Calls since the middle of last week, the WMT 04/20 $95-97.50 Calls. We wanted to provide a quick update on the moves we had witnessed by the end of the week.

At the bottom of the range, the $95 Calls ran from .25 to .51 for a gain of 104%  At the top, we saw the $97.50′s rise from .11 to .24, a 118% rip. The four sets of contracts in between those two also produced opportunities at commensurate profits. With plenty of time prior to expiration, we’ll leave these contracts on our radar and continue to monitor them as we kick off a fresh trading week.


Extended Watchlist:
CSIQ, RKDA, OPTT, FSCS, JKS, VIVE, HRTX, FNF

Blue Horseshoe Stocks: ECYT Recap & More

Endocyte, Inc. ECYT

Our first order of business this morning is to review the recent performance of ECYT, which we initially slated for observation in our report on February 28th. At the time, the stock had been slowly gaining momentum for much of February, and it looked ripe for a more pronounced breakout.

That day, as the stock was trading for as little as 4.51, we witnessed an explosion in volume that has precipitated a very impressive run, persisting for over two weeks up to the present time. Yesterday’s session brought a new high of 11.54 in ECYT, which marks an upswing of 156% in a relatively short time frame.


Valeant Pharma International, Inc. VRX

On Monday morning, we came up with some options ideas for VRX, which we noted was “ready for a bottom bounce”. We also made reference to a huge Form-4 buy of $108.8M came in as well, which led us to postulate that “for now the stock has gone as low as it’s going to go.”

We couldn’t have been any more spot-on in our assessment of VRX, and the result has been a solid performance for the short-term calls we put on watch, the VRX Weekly $15 & $15.50 Calls. The $15′s ran from .65-1.15 for a gain of 77%, while the $15.50′s moved from a low of .30 to .71, an increase of 137%

We had some longer-term ideas as well which we will likely come back to in an upcoming report, as it appears VRX will continue to head up. On that note, we’ll also look to roll up our strike prices on the weekly calls to the $16 & $16.50′s.

_______________

Fresh Options Idea:

Walmart, Inc. WMT 04/20 $95-97.50 Calls


Extended Watchlist:
RKDA, EXPR, NCTY, VYGR, TYME, MARA